Scarica l'app Stockscreener
88.32
3.95%
-3.63
Dopo l'orario di chiusura:
88.32
Vaxcyte Inc Borsa (PCVX) Ultime notizie
Vaxcyte, Inc. (NASDAQ:PCVX) Receives Average Rating of "Buy" from Analysts - MarketBeat
Vaxcyte to Present at the Guggenheim SMID Cap Biotech Conference - The Manila Times
Vaccine Innovator Vaxcyte Takes Center Stage at Elite Guggenheim Biotech Conference - StockTitan
Kuehn Law Encourages Investors of Vaxcyte, Inc. to Contact Law Firm - GlobeNewswire Inc.
(PCVX) Proactive Strategies - Stock Traders Daily
Andrew Guggenhime Sells 8,000 Shares of Vaxcyte, Inc. (NASDAQ:PCVX) Stock - MarketBeat
Cantor Fitzgerald Predicts Vaxcyte FY2025 Earnings - MarketBeat
Vaxcyte president and CFO sells shares worth $692,100 - MSN
Vaxcyte president and CFO sells shares worth $692,100 By Investing.com - Investing.com South Africa
CARGO Therapeutics, Inc. Enters into Sublease Agreement with Vaxcyte, Inc -July 08, 2024 at 04:18 pm EDT - Marketscreener.com
Vaxcyte Catapults As It Looks To Take On Pfizer, Merck In A Massive Market - MSN
Why Vaxcyte, Inc. (PCVX) Is One of the Best Russell 2000 Stocks to Invest in According to Analysts? - Insider Monkey
Vaxcyte (NASDAQ:PCVX) Trading Up 7.8%Should You Buy? - MarketBeat
Teri Loxam Sells 6,250 Shares of Vaxcyte, Inc. (NASDAQ:PCVX) Stock - MarketBeat
Alexandria Announces Long-Term Lease at San Carlos Mega Campus - MSN
Learn to Evaluate (PCVX) using the Charts - Stock Traders Daily
Vaxcyte (NASDAQ:PCVX) Stock Price Up 7.8%Here's What Happened - MarketBeat
Vaxcyte Aims To Outshine Pfizer With Bold VAX-31 Strategy (NASDAQ:PCVX) - Seeking Alpha
Leerink Partnrs Forecasts Vaxcyte FY2029 Earnings - MarketBeat
Vaxcyte, Inc. (NASDAQ:PCVX) Shares Bought by Harbor Capital Advisors Inc. - MarketBeat
Diversified Trust Co Acquires New Holdings in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Vaxcyte's SVP Mikhail Eydelman sells $427,922 in stock - Investing.com India
Vaxcyte's SVP Mikhail Eydelman sells $427,922 in stock By Investing.com - Investing.com Canada
Kuehn Law Encourages Investors of Vaxcyte, Inc. to Contact Law Firm - The Malaysian Reserve
Long Term Trading Analysis for (PCVX) - Stock Traders Daily
Brokerages Set Vaxcyte, Inc. (NASDAQ:PCVX) Target Price at $145.71 - MarketBeat
Vaxcyte COO Jim Wassil sells shares valued at $669,266 By Investing.com - Investing.com Australia
Jim Wassil Sells 8,000 Shares of Vaxcyte, Inc. (NASDAQ:PCVX) Stock - MarketBeat
Vaxcyte COO Jim Wassil sells shares valued at $669,266 - Investing.com
Vaxcyte, Inc. (NASDAQ:PCVX) Shares Bought by Principal Financial Group Inc. - MarketBeat
Vaxcyte (NASDAQ:PCVX) Trading Down 5.8%Here's What Happened - MarketBeat
When (PCVX) Moves Investors should Listen - Stock Traders Daily
Is Vaxcyte, Inc. (PCVX) the Best Performing Biotech Stock in 2024? - MSN
10 Best Performing Biotech Stocks in 2024 - Insider Monkey
Vaxcyte stock supported by Goldman Sachs for addressing next-gen vaccine challenges - Investing.com Canada
Vaxcyte a new buy at Goldman Sachs on vaccine platform, pneumonia asset - MSN
Vaxcyte a new buy at Goldman Sachs on vaccine platform, pneumonia asset (PCVX:NASDAQ) - Seeking Alpha
Vaxcyte (NASDAQ:PCVX) Coverage Initiated at The Goldman Sachs Group - MarketBeat
Vaxcyte's president and CFO sells $710,248 in stock transactions - Investing.com India
Vaxcyte's president and CFO sells $710,248 in stock transactions By Investing.com - Investing.com Canada
Insider Selling: Vaxcyte, Inc. (NASDAQ:PCVX) CFO Sells 8,000 Shares of Stock - MarketBeat
Vaxcyte’s president and CFO sells $710,248 in stock transactions By Investing.com - Investing.com Nigeria
3.95%
2.39%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):